![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Prostate Cancer |
Free Subscription
1 Br J Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Fascin-1 expression is associated with neuroendocrine prostate cancer and
directly suppressed by androgen receptor.
Br J Cancer. 2023 Oct 24. doi: 10.1038/s41416-023-02449.
PubMed
Abstract available
Progress in reducing cancer mortality in the United States by congressional
district, 1996-2003 to 2012-2020.
Cancer. 2023;129:2522-2531.
PubMed
Abstract available
SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1
transcriptional repression and cell cycle arrest.
Cancer Lett. 2023 Oct 23:216464. doi: 10.1016/j.canlet.2023.216464.
PubMed
Abstract available
Evaluating the Role of Morphological Parameters in the Prostate Transition Zone
in PHI-Based Predictive Models for Detecting Gray Zone Prostate Cancer.
Clin Med Insights Oncol. 2023;17:11795549231201122.
PubMed
Abstract available
Same-day repeatability and Between-Sequence reproducibility of Mean ADC in
PI-RADS lesions.
Eur J Radiol. 2023;165:110898.
PubMed
Abstract available
Reconciling discordance between PI-RADS 4 lesions and targeted biopsy: Early
experience of a multidisciplinary quality improvement protocol with PI-RADS 4
subcategorization.
Eur J Radiol. 2023;165:110929.
PubMed
Abstract available
Radiomics based automated quality assessment for T2W prostate MR images.
Eur J Radiol. 2023;165:110928.
PubMed
Abstract available
Accelerated diffusion-weighted imaging of the prostate using deep learning image
reconstruction: A retrospective comparison with standard diffusion-weighted
imaging.
Eur J Radiol. 2023;165:110953.
PubMed
Abstract available
Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral
zone in men without prostate cancer.
Eur J Radiol. 2023;169:111151.
PubMed
Abstract available
Application of a validated prostate MRI deep learning system to independent
same-vendor multi-institutional data: demonstration of transferability.
Eur Radiol. 2023;33:7463-7476.
PubMed
Abstract available
Re: Patient-reported Outcomes 12 Years after Localized Prostate Cancer Treatment.
Eur Urol. 2023 Oct 19:S0302-2838(23)03157-3. doi: 10.1016/j.eururo.2023.
PubMed
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the
Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Eur Urol. 2023 Oct 18:S0302-2838(23)03158-5. doi: 10.1016/j.eururo.2023.
PubMed
Abstract available
Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven
Programs.
Eur Urol. 2023;84:455-460.
PubMed
Abstract available
Pelvic irradiation for node-positive prostate cancer after prostatectomy:
Long-term results of the prospective PLATIN-4 and PLATIN-5 trials.
Int J Radiat Oncol Biol Phys. 2023 Oct 18:S0360-3016(23)08012.
PubMed
Abstract available
Safety of ultra-hypofractionated pelvic nodal irradiation in the definitive
management of prostate cancer: Systematic Review and Meta-analysis.
Int J Radiat Oncol Biol Phys. 2023 Oct 18:S0360-3016(23)08006.
PubMed
Abstract available
Editorial for "Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate
Cancer Detection".
J Magn Reson Imaging. 2023 Oct 26. doi: 10.1002/jmri.29097.
PubMed
Mental health outcomes in a population-based cohort of patients with prostate
cancer.
J Natl Cancer Inst. 2023 Oct 23:djad175. doi: 10.1093.
PubMed
Abstract available
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate
cancer progression.
Oncogene. 2023 Oct 24. doi: 10.1038/s41388-023-02875.
PubMed
Abstract available
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial
(NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT
within a prospective study.
Prostate. 2023;83:1201-1206.
PubMed
Abstract available
Disease control outcomes of stereotactic body radiation therapy or moderate
hypo-fractionation for prostate cancer: Real-world experience at two Canadian
centers.
Prostate. 2023 Oct 25. doi: 10.1002/pros.24638.
PubMed
Abstract available
A Matched-pair Analysis Comparing Systematic Prostate Biopsy by Conventional
Transrectal Ultrasound-guidance Versus Software-based Predefined 3D-Guidance.
Urology. 2023;177:128-133.
PubMed
Abstract available
Robot-assisted Laparoscopic Prostatectomy After SpaceOAR Placement.
Urology. 2023;177:228-229.
PubMed
Abstract available
Visual Analogue Scale and Expanded Prostate Cancer Index Composite-26 in the
Evaluation of Urinary Continence Recovery After Three-Dimensional Laparoscopic
Radical Prostatectomy, a Single-Center Prospective Registered Study.
Urology. 2023;177:103-108.
PubMed
Abstract available
Thank you for your interest in scientific medicine.